UK markets closed

Cencora, Inc. (COR)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
240.55+2.60 (+1.09%)
As of 01:25PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close237.95
Open239.03
Bid240.51 x 900
Ask240.58 x 800
Day's range238.26 - 241.05
52-week range163.37 - 246.75
Volume368,817
Avg. volume1,266,279
Market cap47.934B
Beta (5Y monthly)0.47
PE ratio (TTM)26.20
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.04 (0.86%)
Ex-dividend date08 Feb 2024
1y target estN/A
All
News
  • Business Wire

    Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release

    CONSHOHOCKEN, Pa., April 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 1, 2024.

  • Business Wire

    Cencora Announces Leadership Succession Plan

    CONSHOHOCKEN, Pa., March 12, 2024--Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024. Robert P. Mauch, PharmD, PhD, current Chief Operating Officer of Cencora, will succeed Collis as President and CEO, and will also be appointed as a member of the Company's Board, effective the same date.

  • Business Wire

    Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

    CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.